Home Non-Invasive Positive Pressure Ventilation (NIPPV) Devices for Respiratory Insufficiency and Failure
Customize your policy alerts
Sign up for univerahealthcare Policy 1.01.57 alerts
Get alerted when Policy 1.01.57 changes without checking for updates manually.
Monitor payer policy activity
Medical necessity and coverage criteria for home non-invasive positive pressure ventilation devices (BPAP and non-invasive home mechanical ventilation) for individuals with respiratory insufficiency due to neuromuscular or thoracic restrictive disease.
New policy to address home ventilation devices for respiratory failure.
Coverage Criteria for Home Non-Invasive Positive Pressure Ventilation
BPAP (E0470/E0471) — Neuromuscular or Thoracic Restrictive Disease
Covered when ANY of the following are met for individuals with neuromuscular or thoracic restrictive disease:
Exact measurement conditions specified in each node
Non-invasive Home Mechanical Ventilation (E0466)
Considered medically appropriate when ALL of the following are met:
Many specific clinical scenarios listed as indications for escalation
Dual or multifunction ventilator (E0468, E0467)
Considered medically necessary when ALL of the following are met:
BPAP without backup rate (E0470) for hypoventilation syndrome
Considered medically appropriate when ALL of the following are met:
Chunk 22
Chunk 23
Chunks 24-25
BPAP with backup rate (E0471) for hypoventilation syndrome
Considered medically appropriate when ALL of the following are met:
Chunk 26
Chunk 27
Chunk 28
Non-invasive home mechanical ventilation devices (E0466) for hypoventilation syndrome
Considered medically appropriate when ALL of the following are met:
Chunk 32
Chunks 33-37
NIPPV (E0466) for hypoventilation syndrome
Covered when ALL of the following are met:
Indication and trial
- Hypercapnia criteria: One of: awake PaCO2 ≥45 mm Hg; OR awake venous PCO2, end-tidal PCO2, or transcutaneous PCO2 ≥50 mm Hg.PaCO2 thresholds as stated
See chunks 36-37
Dual or multifunction ventilators (E0468, E0467)
Covered when BOTH of the following are met:
See chunks 38-39
BPAP without backup rate (E0470) for COPD-related CRF
Covered when ALL of the following are met:
See chunks 40-42
BPAP with backup rate (E0471) for COPD-related CRF
Covered when ALL of the following are met:
See chunks 43-44 and 48
E0466 for COPD-related CRF (advanced non-invasive ventilator)
Covered when ALL of the following are met:
Refer to Policy Statement VIII / chunks 49
See chunks 50-55
Home mechanical ventilator (E0466) for chronic respiratory failure due to COPD
Covered when ALL of the following are met
Advanced BPAP insufficiency criteria
- PaCO2 or symptom response: Stabilization of a rising PaCO2 OR 20% reduction in PaCO2 from baseline OR improvement of at least one symptom associated with chronic hypercapnia.
Must document failure of iVAPS to meet needs
Dual or multifunction ventilators (E0468, E0467)
Covered when BOTH of the following are met
Both conditions required
BPAP (E0471/E0470) for obstructive or central sleep apnea
Covered when ALL of the following are met for OSA, and for central/complex sleep apnea when ONE of the listed indications is met
Any one indication qualifies
Hospital discharge with home ventilator or BPAP with backup
Covered when BOTH of the following are met
Continuation of use
Required to consider continuation medically appropriate
Continuation of NIPPV
Covered when ALL of the following are met
Applies to diagnoses of COPD, OSA, and hypoventilation syndrome
Repair of NIPPV (non-warranty)
Repair considered medically appropriate when ALL of the following physician documentation items are provided and BOTH device function criteria are met
Repair expected to restore manufacturer-defined full functionality
Replacement of NIPPV (non-warranty)
Replacement considered medically appropriate when EITHER of the following is met
Covered when device matches indicated clinical scenarios
Covered indications and device descriptions
Based on BPAP description
From advanced BPAP description
From multifunction ventilator description
Professional guideline–based coverage criteria
Coverage and clinical-use guidance reflected from cited professional societies (condensed):
AASM 2025 guidance
Chest Physicians 2023 guidance
ATS 2020 guidance
AASM/AASM-related guidance
No explicit exclusions are stated in this policy segment. The document affirms that medical necessity criteria and device-specific coverage rules govern authorization decisions, and that contract-dependent product benefits may further limit coverage (e.g., if a product does not cover a service, the medical policy criteria do not apply).
Providers should note that although this excerpt does not list standalone exclusions, other sections of the policy specify ineligible circumstances (see Multifunction device requirements, repair/replacement exclusions, and convenience items) that affect coverage determinations.
Requests for dual- or multifunction ventilators (HCPCS: E0467, E0468) must include documentation that clearly supports the medical need for one or more additional device functions (e.g., oxygen concentrator, cough stimulator, suction pump, nebulizer). The member must not already have received the same function(s) as separate devices; lacking this documentation risks denial.
When multifunction capability is requested, include clinical justification for each additional function and evidence that those functions are required concurrently with ventilation rather than being available from other covered equipment.
If sleep apnea is the underlying cause of hypercapnia and has not been ruled out, criteria for BPAP without backup (HCPCS: E0470) are not met. Documentation must establish that hypercapnia is not attributable to untreated sleep-disordered breathing before E0470 is approved.
Multifunction devices are considered medically necessary only when documentation demonstrates the need for additional non-ventilator functions and confirms that the member has not previously been provided those functions as standalone devices. Absent this documentation, multifunction device requests may be denied.
Repairs or replacements for equipment damaged by patient neglect, theft, or abuse are ineligible for coverage. Coverage is also ineligible when another available source (e.g., homeowners, rental, auto, liability insurance) can reasonably cover the loss or damage.
When alternate coverage exists, providers should direct members to the alternate source; requests for plan payment in these circumstances are subject to denial.
Replacement of a properly functioning NIPPV device for convenience, aesthetics, or to obtain advanced technology is considered not medically necessary and is excluded. Accessories or components deemed not medically necessary or investigational in peer-reviewed literature are likewise ineligible.
Requests that do not document loss of function, non-repairability, or a clinical change that renders the current device inadequate will not meet the replacement criteria.
Devices intended solely to clean or sanitize BPAP equipment (for example, SoClean or SoClean 2 Go) are considered convenience items and are not eligible for coverage under this policy.
The policy’s HCPCS/CPT/ICD-10 code lists may not be exhaustive. Specific codes could be excluded or not covered under certain circumstances; check the full policy and the member’s product benefit for applicability.
Providers must submit the relevant procedure and diagnosis codes when requesting coverage, and be aware that codes alone do not guarantee coverage if other medical-necessity criteria are unmet.
If a member’s product does not cover a particular service, the medical policy criteria do not apply. Coverage determinations are therefore subject to contract-level benefit limitations; verify product-specific benefit coverage before requesting authorization.
This document segment does not include explicit statements labeled “Not Medically Necessary.” Coverage stance and exclusions are instead captured through the specific device criteria, repair/replacement rules, and explicit ineligibility statements elsewhere in the policy.
Authorization for a home mechanical ventilator (HCPCS: E0466) generally requires prior trial and failure of BPAP (HCPCS: E0470 or E0471) with documentation of attempted daily use when persistent hypercapnia is the indication. Requests for E0466 without evidence of an adequate BPAP trial and daily-use documentation may be considered unsupported.
Where BPAP had not been tried or trial documentation is absent, include objective measures (e.g., ABG or PCO2 monitoring) and a narrative explaining why BPAP trial was not feasible to reduce risk of denial.
If an advanced BPAP mode such as iVAPS (referenced with HCPCS: E0471) adequately meets the patient’s ventilatory needs, escalation to a home mechanical ventilator (HCPCS: E0466) is not indicated. E0466 is considered only when advanced BPAP/iVAPS cannot achieve required physiologic goals (e.g., normalization or stabilization of PaCO2, ≥20% PaCO2 reduction, or improvement in hypercapnia-related symptoms).
Document attempts to optimize advanced BPAP/iVAPS settings and the physiologic or symptomatic endpoints that were not achieved to support an E0466 request.
Requests for HCPCS E0466 may be deemed not medically necessary if there is no documentation that advanced BPAP with iVAPS (HCPCS: E0471) is insufficient or that the listed PaCO2/symptom criteria for escalation are unmet.
Prior authorization submissions for E0466 should therefore include evidence of failed advanced BPAP/iVAPS and the specific physiologic or symptom-based endpoints used to justify escalation.
Replacement of a properly functioning home NIPPV device, its components, or accessories is considered not medically necessary. Requests to replace equipment for reasons other than non-repairability, excessive repair cost, or clinically driven changes in patient needs should be denied.
BPAP devices that include volume- or pressure-based backup-rate features have not demonstrated effectiveness for treating obstructive sleep apnea (OSA). For OSA management, CPAP remains first-line; BPAP (with or without backup) is used when CPAP is not tolerated or does not control events.
Because backup-rate BPAP has not shown effectiveness for OSA, requests for such devices to treat uncomplicated OSA should include documentation showing CPAP failure or intolerance and clinical justification for BPAP.
The policy uses code-designation labels such as (E/I)=Experimental/Investigational and (NMN)=Not medically necessary/appropriate where applicable; review the full policy coding table to see code-specific designations and applicability.
Coding and Clinical Thresholds
| E0466 | Non-invasive home mechanical ventilation device |
| E0466 | Non-invasive home mechanical ventilator |
| A9279 | Monitoring feature/device, stand-alone or integrated, any type, including all accessories, components, and electronics, not otherwise classified |
| CPT Codes | Listed in policy (detailed list not present in this excerpt) |
| No codes listed |
| A7027-A7039 | Accessories/supplies, code range for positive pressure airway devices (code range). |
| A7044- | Accessories/supplies, code range for positive pressure airway devices (code range). |
| A9279 | Monitoring feature/device, stand-alone or integrated, any type, includes all accessories, components and electronics, not otherwise classified. |
| E0466 | Home ventilator, any type, used with noninvasive interface, (e.g., mask, chest shell). |
| E0467 | Home ventilator, multi-function respiratory device, also performs functions of oxygen concentration, drug nebulization, aspiration, and cough stimulation. |
| E0468 | Home ventilator, dual-function respiratory device, also performs additional function of cough stimulation. |
| E0470 | Respiratory assist device, bi-level pressure capability, without back-up rate feature, used with noninvasive interface. |
| E0471 | Respiratory assist device, bi-level pressure capability, with backup rate feature, used with noninvasive interface. |
| E0472 | Respiratory assist device, bi-level pressure capability, with backup rate feature, used with invasive interface. |
| E0561 | Humidifier, nonheated, used with positive airway pressure device. |
| E66.2 | Morbid (severe) obesity with alveolar hypoventilation. |
| G12.0-G12.9 | Spinal muscular atrophy and related syndromes (code range). |
| G35 | Multiple sclerosis. |
| G47.00 | Insomnia, unspecified. |
| G47.10 | Hypersomnia, unspecified. |
| G47.20 | Circadian rhythm sleep disorder, unspecified type. |
| G47.35 | Congenital central alveolar hypoventilation syndrome. |
| G47.8 | Other sleep disorders. |
| G47.9 | Sleep disorder, unspecified. |
| I50.9 | Heart failure, unspecified. |
Authorization, Documentation, and Billing Actions for Providers
Prior authorization required for BPAP and home ventilator codes
Prior authorization is required for BPAP (HCPCS E0470/E0471) and non-invasive home mechanical ventilation (HCPCS E0466). Submit clinical documentation demonstrating that the device-specific medical necessity criteria in the policy are met.
PA required for home ventilator devices (E0466/E0467/E0468)
Prior authorization is required for specified home ventilator HCPCS codes (including E0466, E0467, E0468) and must show that the medical necessity criteria for a home mechanical ventilator are met.
- Ensure documentation shows the patient meets the home mechanical ventilator criteria before submission
PA for multifunction / dual ventilators (E0467, E0468)
Prior authorization is required for multifunction or dual ventilators (HCPCS E0467, E0468) and must include documentation supporting the need for device-level additional functions not previously provided individually.
- Document which additional functions (oxygen concentrator, cough stimulator, suction pump, nebulizer) are required and confirm they were not previously provided separately
PA required showing HCPCS device criteria are met (e.g., E0466)
Prior authorization is required for HCPCS-coded devices and requests must demonstrate device-specific clinical criteria are met (for example, E0466 for COPD-related chronic respiratory failure where advanced BPAP/iVAPS is insufficient).
- Provide device-specific physiologic data and documentation of prior device trials per the criteria
Prior authorization for repair or replacement of non-warranty NIPPV
Prior authorization/approval is required to authorize repair or replacement of non-warranty NIPPV devices; replacement is allowed when the device is non-repairable, repair cost exceeds replacement cost, or a change in patient condition makes the current unit nonfunctional and replacement is expected to improve function.
- Include physician documentation items (date of DME initiation, warranty info, attestation of compliance) and device-function evidence
One-month rental allowed during out-of-warranty repair; monitoring inclusive
A one-month rental is allowed when a home ventilation device is malfunctioning and out of warranty while being repaired; monitoring features (HCPCS A9279) are considered inclusive to the positive airway pressure device.
- Rental coverage limited to one month during out-of-warranty repair
- Do not bill monitoring feature separately when included (A9279 considered inclusive)
FDA clearance and code-specific coverage note
FDA clearance is required for BPAP and home ventilators; coverage may depend on code-specific rules and exclusions listed by the payer.
- Confirm devices have FDA approval before marketing/use and verify code-specific coverage rules
Obtain authorization when product requires it (HCPCS presence implies PA)
Authorization is expected when device HCPCS codes are used and the member's product requires prior approval — providers should obtain authorization when the member's product requires it.
- Presence of device HCPCS codes implies prior authorization may be required by the product
Step-up to E0466 when BPAP is insufficient and listed indications present
E0466 (non-invasive home mechanical ventilation) is authorized when BPAP (E0470/E0471) is insufficient and one of the listed indications for escalation (e.g., need for auto-EPAP, concomitant OSA, bulbar dysfunction, concomitant COPD, >10 hours/day NIV need) is present.
- Document that advanced BPAP/iVAPS does not meet respiratory needs and specify which escalation indication applies
Require documented BPAP trial and failure before escalation
A documented trial and failure of BPAP with evidence of attempted daily use is required before progressing to some advanced ventilator devices (such as E0466).
- Include documentation of attempted daily BPAP use and persistent hypercapnia per thresholds
Use BPAP when CPAP fails or is not tolerated for OSA
For obstructive sleep apnea, BPAP (E0471/E0470) is appropriate when CPAP has failed or is not tolerated and documentation demonstrates improved control of respiratory events and tolerance with BPAP.
- Provide evidence of CPAP failure/intolerance and BPAP effectiveness (at least 2 weeks post-acute episode when applicable)
Consider repair before replacement unless infeasible or cost-prohibitive
Repair should be considered prior to replacement unless repair is non-feasible or cost-prohibitive compared with replacement.
- Document why repair is not feasible or is more costly than replacement when requesting replacement
BPAP with expiratory relief as CPAP-intolerance alternative
BPAP with expiratory relief may be used as an alternative for patients who cannot tolerate the high constant pressure associated with CPAP.
- Document intolerance to CPAP high pressures and rationale for selecting BPAP with expiratory relief
CPAP first-line for OSA; escalate to BPAP if CPAP fails or events persist
CPAP is supported as first-line therapy for OSA; transition to BPAP is appropriate if CPAP intolerance or persistent obstructive events at high CPAP pressures occur per AASM guidance.
- Reference AASM guidance and document CPAP failure/intolerance or persistent events at high pressures
Submit required clinical test results (FVC, MIP, sleep oximetry, ABG PaCO2)
Provide required clinical test results to support medical necessity: measured FVC percent predicted, maximal inspiratory pressure (MIP), sleep oximetry showing cumulative desaturations, and arterial blood gas (ABG) with PaCO2.
- FVC: <80% predicted with symptoms or <50% without symptoms
- MIP: <60 cm H2O
- Sleep oximetry: ≤88% for ≥5 cumulative minutes (min 2-hour recording)
- ABG PaCO2: ≥45 mm Hg (awake)
Document device functions and BPAP trial/usage
Documentation must support the need for device functionalities and show attempted daily use when BPAP was tried and failed; include device function evidence when requesting multifunction devices or upgrades.
- For multifunction devices, document which functions are required and that they were not already provided separately
- For E0466 escalation, include documentation of attempted daily BPAP use
Include objective CO2 measurements and ABG change comparisons
Include objective CO2 measurements in documentation: awake ABG PaCO2 and, when applicable, venous/end-tidal/transcutaneous PCO2, and ABG comparisons showing changes (e.g., worsening ≥10 mm Hg versus qualifying ABG).
- Awake PaCO2 thresholds: ≥45 mm Hg (general) and ≥52 mm Hg for COPD CRF E0470
- Report worsening PaCO2 ≥10 mm Hg compared to qualifying ABG when required
Document necessity of non-ventilator functions for multifunction devices
Documentation must support the need for non-ventilator functions on multifunction devices and indicate that the member has not previously received those functions as separate devices.
- Specify which non-ventilator functions are needed (oxygen, cough assist, suction, nebulizer)
- Confirm member has not already received those functions separately
Document ventilator/BPAP requirement within 24 hours before discharge
For hospital discharge with a home ventilator or BPAP with backup, documentation must show the patient required a ventilator or BPAP within 24 hours prior to discharge and is at risk of rapid symptom exacerbation or rise in PaCO2 after discharge.
- Include timing of ventilator/BPAP use within 24 hours of discharge and risk rationale
Physician documentation required for repair/replacement requests
For repair or replacement requests, include physician documentation items: date of DME initiation, manufacturer warranty information (if applicable), and an attestation that the patient has been compliant and will continue to benefit from the DME.
- Provide DME initiation date and warranty details
- Include clinician attestation of patient compliance and ongoing benefit
Document inadequate device function and impact on ADLs for repair/replacement
Document that the device is no longer functioning adequately, that inadequate function interferes with activities of daily living, and that repair is expected to restore full functionality per manufacturer definition.
- Describe how inadequate function affects ADLs and why repair would restore functionality
Require clinical reevaluation and corrective plan after failed initial trial
Clinical reevaluation by the treating physician is required to document the etiology of failure to respond (e.g., persistent symptoms, improper fit) and a corrective plan (re-education, mask refitting) to re-qualify after an unsuccessful initial trial.
- Include findings on etiology and planned corrective actions when submitting for re-qualification
Document PAP education, mask fitting, and titration per AASM
Provide documentation of PAP education, hands-on demonstration, careful mask fitting, acclimatization, and titration details when applicable, consistent with AASM pre-titration and titration guidance.
- Document pre-titration education, mask fitting, and any repeat titration details
Submit relevant CPT/HCPCS and ICD-10 codes with requests
Submit all relevant CPT/HCPCS and ICD-10 codes listed in the policy when requesting coverage for home NIPPV devices to support claims and authorization requests.
Denial risk for missing required clinical documentation
Lack of required clinical documentation (e.g., no FVC or MIP measurements, absent ABG demonstrating PaCO2 ≥45 mm Hg, or missing nocturnal oximetry findings) may lead to denial of the request.
- Ensure FVC, MIP, ABG PaCO2, and sleep oximetry data are included when applicable
Denial risk for missing required CO2 documentation
Requests lacking documented hypercapnia by the policy thresholds (awake PaCO2 ≥45 mm Hg; or venous/end-tidal/transcutaneous PCO2 ≥50 mm Hg; or PaCO2 ≥52 mm Hg for COPD CRF BPAP without backup) may be denied.
- Include specific CO2 measurements and indicate which threshold applies to the indication
Denial risk for E0466 requests without evidence advanced BPAP/iVAPS failed
A request for a home mechanical ventilator (E0466) for COPD-related chronic respiratory failure may be denied if documentation does not show that advanced BPAP with iVAPS (E0471) is insufficient or that one of the listed PaCO2/symptom criteria is met.
- Document failure of advanced BPAP/iVAPS and inability to achieve PaCO2 goals or symptom improvement as specified
Denial risk for dual/multifunction devices lacking function necessity evidence
Dual (E0468) or multifunction (E0467) device requests may be denied if documentation does not support the need for one or more additional functions or if those functions were already provided individually.
- Clearly state which additional functions are required and verify they were not previously provided separately
Ineligible: damage/theft/alternate coverage — risk of denial
Repairs or replacements for equipment damaged due to patient neglect, theft, or abuse, or when another coverage source is available, are ineligible for coverage and may be denied.
- Do not submit repair/replacement claims for neglect/theft/abuse or when alternate coverage exists
Loss of coverage risk if continuation trial criteria not met (90-day trial)
Failure to meet continuation criteria during the initial 90-day trial may result in loss of coverage until a clinical reevaluation determines the etiology of failure and appropriate corrective actions are documented.
- If continuation criteria not met, submit clinical reevaluation documenting etiology and corrective plan (re-education, mask refit)
Coding and coverage limitations — verify with payer
Codes listed in the policy may not be covered under all circumstances and the code list may not be all inclusive; verify coverage and code applicability with the payer.
- Confirm code coverage and any payer-specific exclusions before submission
Coverage depends on member product — verify contract benefits
Services are contract dependent; if a product does not cover a service, the medical policy criteria do not apply — risk of denial if the member's product excludes the service.
- Check the member's product benefits for coverage before submitting authorization requests
Background and Scope
Background: This policy addresses use of bilevel positive airway pressure (BPAP) devices (HCPCS E0470, E0471) and non-invasive home mechanical ventilation (HCPCS E0466, E0467, E0468) for respiratory insufficiency and failure related to neuromuscular or thoracic restrictive disease and other causes of chronic respiratory failure. It defines physiologic thresholds, escalation pathways (including when BPAP is insufficient and a home ventilator is indicated), and device-specific documentation and authorization expectations.
Definitions and Device Descriptions
Policy Revision History
Committee approved new policy (1.01.57) establishing coverage for home non-invasive positive pressure ventilation; criteria for BPAP were moved from policy 1.01.06.
Policy 1.01.57 effective date set for implementation of coverage criteria for home ventilation devices.
OpenPayer is powered by Trek Health's payer performance platform. Trek continuously ingests, validates, and normalizes Transparency in Coverage data alongside payer policies and other commercial payer data to create a structured payer intelligence foundation. OpenPayer uses this foundation to deliver personalized search results, dynamically generated policy pages, and tailored policy monitoring based on each user's payers, specialties, billing codes, and areas of interest. The same intelligence powers broader payer performance workflows, including reimbursement benchmarking, contract evaluation, payer negotiations, and financial decision-making.